Timon Vandamme
Overview
Explore the profile of Timon Vandamme including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chan J, Ribeiro-Oliveira Jr A, Houchard A, Dennen S, Liu Y, Naga S, et al.
Adv Ther
. 2025 Mar;
PMID: 40080241
Introduction: This study investigated the burden of comorbidities and concomitant non-cancer medications and their cost in patients with neuroendocrine tumors (NETs). Methods: Adults with gastroenteropancreatic (GEP)-NETs and lung-NETs, with or...
2.
Debie Y, Garcia-Fogeda I, Willem L, Roelant E, Verbruggen L, Vanhoutte G, et al.
Sci Rep
. 2025 Mar;
15(1):7858.
PMID: 40050359
The level of protection against SARS-CoV-2 breakthrough infections conferred by the presence of anti-S1 SARS-CoV-2 antibodies (IgGs) in cancer patients is still understudied. This work examines the existence of an...
3.
Islam O, Islam O, Sarti K, Sarti K, Verbruggen L, Verbruggen L, et al.
Endocr Relat Cancer
. 2025 Jan;
32(4).
PMID: 39888333
Gastroenteropancreatic neuroendocrine neoplasms (GEP NEN) exhibit substantial biological heterogeneity, impacting clinical management and outcomes. In 2019, the WHO subdivided the grade 3 (G3) neuroendocrine neoplasms (NEN) characterised by Ki-67 >...
4.
Maly M, Callebout E, Ribeiro S, Hoorens A, Carton S, Cuyle P, et al.
J Neuroendocrinol
. 2024 Nov;
37(1):e13473.
PMID: 39604221
The prevalence of gastric NEN is estimated worldwide at 8.9% of all gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) and only 0.3%-1% of all gastric neoplasms, but is rising in the last decades....
5.
Pieterman C, Grozinsky-Glasberg S, OToole D, Howe J, Ambrosini V, Belli S, et al.
J Neuroendocrinol
. 2024 Nov;
37(1):e13468.
PMID: 39587981
Multiple Endocrine Neoplasia type 1 (MEN1) Clinical Practice Guidelines (2012) are predominantly based on expert opinion due to limited available evidence at the time, leaving room for interpretation and variation...
6.
Assaf I, Bregni G, Anthoine G, Aparicio T, Artru P, Abdelghani M, et al.
Clin Colorectal Cancer
. 2024 Sep;
24(1):101-105.
PMID: 39341700
Background: Evidence suggests that ctDNA may be a reliable biomarker to monitor metastatic colorectal cancer (CRC) evolution. Nevertheless, evidence on the potential of liquid biopsy in this setting is still...
7.
van der Graaff D, Seghers S, Vanclooster P, Deben C, Vandamme T, Prenen H
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123399
Colorectal cancer (CRC) remains a significant health burden globally, being the second leading cause of cancer-related mortality. Despite significant therapeutic advancements, resistance to systemic antineoplastic agents remains an important obstacle,...
8.
Debie Y, Palte Z, Salman H, Verbruggen L, Vanhoutte G, Chhajlani S, et al.
Qual Life Res
. 2024 Jul;
33(10):2845-2853.
PMID: 38961007
Introduction: Long COVID is defined as the continuation of symptoms, unexplainable by alternative diagnosis, longer than four weeks after SARS-CoV-2 infection. These symptoms might hinder daily activities and overall well-being,...
9.
Leupe H, Pauwels E, Vandamme T, Van den Broeck B, Lybaert W, Dekervel J, et al.
J Neuroendocrinol
. 2024 Jun;
36(8):e13420.
PMID: 38837825
[F]AlF-NOTA-octreotide ([F]AlF-OC) is a promising alternative for [Ga]Ga-DOTA-somatostatin analogs (SSAs) in positron emission tomography (PET) imaging of the somatostatin receptor (SSTR). Our aim is to assess changes in TNM staging...
10.
Daems E, Bassini S, Marien L, Op de Beeck H, Stratulat A, Zwaenepoel K, et al.
Biosens Bioelectron
. 2024 Jan;
249:115957.
PMID: 38199080
Single nucleotide point mutations in the KRAS oncogene occur frequently in human cancers, rendering them intriguing targets for diagnosis, early detection and personalized treatment. Current detection methods are based on...